NH

Nur Hussain Mondal

Active Director Director DIN 08919734
DIN 08919734 First appointment Oct 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Nur Hussain Mondal

Data last updated:

Nur Hussain Mondal is a Director at Biochemist Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Biochemist Pharmaceuticals Private Limited reported revenue of ₹85.8 Lakh (FY 2025).

DIN 08919734
Primary Designation Director
Industry Chemicals
First Appointment 15 Oct 2020
Oldest Company Age 6 yrs
Largest company Biochemist Pharmaceuticals Private Limited · ₹85.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Oct 20202020₹85.8 Lakh (FY 2025)Active

Board colleagues of Nur Hussain Mondal

NameDINCompanyDesignation
Aminul Islam08919735Biochemist Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biochemist Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nur Hussain Mondal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nur Hussain Mondal

Nur Hussain Mondal currently holds 1 directorship: Biochemist Pharmaceuticals Private Limited (Director, since 15 Oct 2020, revenue ₹85.8 Lakh (FY 2025)).

Nur Hussain Mondal was first appointed on 15 Oct 2020 as Director at Biochemist Pharmaceuticals Private Limited.

The current boards of Nur Hussain Mondal's companies include Aminul Islam (Biochemist Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available